C.H.U. Sart-Tilman — Liège

Please select the option that best describes you so we can direct you to the right page.

🧭 I'm a patient or caregiverWhat this page is, and how to find trials near you

This page counts public registry records — it is not a list of trials you can join.

Studies recruiting near Liège →

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work in clinical researchVerify this profile and open the full entry list

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of C.H.U. Sart-Tilman, compiled from the ClinicalTrials.gov public registry.

20

Registered studies

6

Active

4

Recruiting now

12

Completed

1

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Limited Stage Small Cell Lung Cancer · Diffuse Midline Glioma, H3 K27M-Mutant · Acute Myeloid Leukemia (AML)

Recently updated registry entries

NCT02834884 — SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access (Recruiting)
NCT03859453 — Follow-up in Early and Locally Advanced Breast Cancer Patients (Completed)
NCT03609047 — Adjuvant Palbociclib in Elderly Patients With Breast Cancer (Active Not Recruiting)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 08, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.